After two years of negotations, the WHA agreed a package of critical amendments to the International Health Regulations (2005), and made concrete commitments to completing negotiations on a global pandemic agreement within a year, at the latest.

ECDC, ECHA, EEA, EFSA and EMA publishes a joint framework for action to strengthen cooperation to support the implementation of the One Health agenda in the European Union.

Building on the 2023 session held at the ESWI conference in Valencia "RSV Looking towards the future", this one-day summit concentrated on the healthcare and economic impact of RSV disease, along with the potential solutions expected in the near future.

With promising developments in the field of respiratory viral infections, the conference sessions covered hot topics on seasonal, pandemic, and zoonotic influenza viruses, as well as other respiratory viruses such as RSV and SARS-CoV-2.

Health is one of the main issues on the minds of voters (32%) together with the fight against poverty and social exclusion (33%).

Adult vaccines can return up to 19 times their initial investment to society, when their significant benefits beyond the healthcare system are monetised. This report has been conducted by the Office of Health Economics.

The decision came following two weeks of intensive country-led discussions on critical subjects aimed at making all countries of the world better prepared for, and able to effectively and equitably respond to, future pandemics.

More than four years on since the start of the Covid-19 pandemic, this paper provides an assessment of reforms implemented at EU level to enhance the EU’s preparedness and response to future health threats.

Civil organisations, patients’ advocacy groups and healthcare professional associations urge European policymakers to address the health workforce crisis by implementing solutions that prioritise the well-being of health workers.

In this episode, ECDC expert on respiratory viruses, Nick Bundle, gives the lowdown on the European Respiratory Virus Surveillance Summary (ERVISS), a new surveillance tool which presents weekly data on influenza, SARS-CoV-2 and RSV.

The discussions highlighted the crucial role of prevention, treatment and access to immunisation programmes to raise awareness and decrease the cases of RSV hospitalisations and deaths of young children and older adults.

Ahead of European Patients’ Rights Day, Mariano Votta, Director of Active Citizenship Network, discusses how the event will tackle the skills shortage, medical desertification and job strain in the healthcare sector.